BELITE BIO, INC 20-F filing
Filed 2026-03-31 · Report date 2025-12-31 · 2025
Filing metadata
- Accession number
- 0001104659-26-037374
- Form type
- 20-F
- CIK
- 0001889109
- Primary document
- https://www.sec.gov/Archives/edgar/data/1889109/000110465926037374/blte-20251231x20f.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BELITE BIO, INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-84.2M | - | - |
| Net Income | $-77.6M | - | - |
| Eps Basic | -2.31 | - | - |
| Eps Diluted | -2.31 | - | - |
| Cash And Equivalents | $352.9M | - | - |
| Total Assets | $780.6M | - | - |
| Total Liabilities | $10.1M | - | - |
| Shareholders Equity | $770.5M | - | - |
| Operating Cash Flow | $-37.0M | - | - |
| Capital Expenditures | $71,000 | - | - |